-
Prevention of preterm delivery in twin gestations (PREDICT): A multicentre randomised placebo-controlled trial on the effect of vaginal micronised progesterone.
Rode L, Klein K, Nicolaides K, Krampl-Bettelheim E, Tabor A.
Ultrasound Obstet Gynecol 2011;38:272-80. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Turning the pyramid of prenatal care.
Nicolaides KH.
Fetal Diagn Ther 2011;29:183-96. -
Vaginal micronized progesterone and the risk of preterm delivery in high-risk twin pregnancies - secondary analysis of a placebo-controlled randomized trial and meta-analysis.
Klein K, Rode L, Nicolaides K, Krampl-Bettelheim E, Tabor A.
Ultrasound Obstet Gynecol 2011;38:281-7. -
Prediction of spontaneous preterm delivery from endocervical length at 11 to 13 weeks.
Greco E, Lange A, Ushakov F, Calvo JR, Nicolaides KH.
Prenat Diagn 2011;31:84-9. -
Maternal serum alpha-fetoprotein in normal pregnancy at 11-13 weeks' gestation.
Bredaki FE, Wright D, Akolekar R, Cruz G, Nicolaides KH.
Fetal Diagn Ther 2011;30:274-9. -
Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11-13 weeks.
Beta J, Akolekar R, Ventura W, Syngelaki A, Nicolaides KH.
Prenat Diagn 2011;31:75-83. -
Maternal serum a-fetoprotein at 11-13 weeks' gestation in spontaneous early preterm delivery.
Beta J, Bredaki FE, Calvo JR, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2011;30:88-93. -
Maternal serum progesterone-induced blocking factor at 11-13 weeks gestation in spontaneous early preterm delivery.
Beta J, Szekeres-Bartho J, Skyfta E, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2011;29:197-200. -
Maternal thyroid function at 11-13 weeks of gestation and spontaneous preterm delivery.
Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH.
Obstet Gynecol 2011;117:293-8. -
First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.
Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH.
Prenat Diagn 2009;29:553-9. -
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH.
Obstet Gynecol 2008;31:147-52. -
First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.
Poon LC, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH.
Obstet Gynecol 2008;112:1082-90. -
Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment.
Celik E, To M, Gajewska K, Smith GC, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:549-54. -
Assessment of the corpus callosum at 20-24 weeks' gestation by three-dimensional ultrasound examination.
Plasencia W, Dagklis T, Borenstein M, Csapo B, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:169-72. -
Shirodkar versus McDonald Cerclage for the Prevention of Preterm Birth in Women with Short Cervical Length.
Odibo AO, Berghella V, To MS, Rust OA, Althuisius SM, Nicolaides KH.
Am J Perinatol 2007;24:55-60. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Progesterone and the risk of preterm birth among women with a short cervix.
Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH.
N Engl J Med 2007;357:462-9. -
Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial.
Alfirevic Z, Allen-Coward H, Molina F, Vinuesa CP, Nicolaides K.
Ultrasound Obstet Gynecol 2007;29:47-50. -
Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor.
Tsoi E, Akmal S, Geerts L, Jeffery B, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:368-72.